Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer

Annals of Oncology

Volumn 17, Issue 4, 2006, Pages 543-552

  De Ruysscher, Dirk ^a,b   Pijls Johannesma, M ^b   Vansteenkiste, J ^c   Kester, A ^e   Rutten, I ^d   Lambin, P ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRO CLINIC   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Limited stage; Meta analysis; Review; Small cell lung cancer; Timing radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; PLATINUM DERIVATIVE;

BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; ESOPHAGITIS; HUMAN; LUNG SMALL CELL CANCER; META ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; REVIEW; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SYSTEMATIC REVIEW;

CARCINOMA, SMALL CELL; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS;

EID: 33645304581     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj094     Document Type: Review

References (34)

1. Bunn PA Jr, Carney DN. Overview of chemotherapy for small cell lung cancer. Semin Oncol 1997; 24 (2 Suppl 7): S7-69-S7-74.
2. Stupp R, Monnerat C, Turrisi AT, 3rd, Perry MC, Leyvraz S. Small cell lung cancer: State of the art and future perspectives. Lung Cancer 2004; 45: 105-117.
3. Kelly K. New chemotherapy agents for small cell lung cancer. Chest 2000; 117 (4 Suppl 1): 156S-162S.
4. Pignon JP, Arriagada R, Ihde DC et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327: 1618-1624.
5. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992; 10: 890-895.
6. Kumar P. The role of thoracic radiotherapy in the management of limited-stage small cell lung cancer: Past, present, and future. Chest 1997; 112 (4 Suppl): 259S-265S.
7. De Ruysscher D, Vansteenkiste J. Chest radiotherapy in limited-stage small cell lung cancer: Facts, questions, prospects. Radiother Oncol 2000; 55: 1-9.
8. Pijls-Johannesma MCG, De Ruysscher DKM, Rutten I, Vansteenkiste JF, Lambin P. Early versus late chest radiotherapy for limited-stage small cell lung cancer (Cochrane review). The Cochrane Library (Issue 1) 2005.
9. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-146.
10. Bentzen SM, Thames HD. Clinical evidence for tumor clonogen regeneration: Interpretations of the data. Radiother Oncol 1991; 22: 161-166.
11. Davis AJ, Tannock JF. Repopulation of tumour cells between cycles of chemotherapy: A neglected factor. Lancet Oncol 2000; 1: 86-93.
12. Davis AJ, Tannock IF. Tumor physiology and resistance to chemotherapy: repopulation and drug penetration. Cancer Treat Res 2002; 112: 1-26.
13. Wu L, Tannock IF. Repopulation in murine breast tumors during and after sequential treatments with cyclophosphamide and 5-fluorouracil. Cancer Res 2003; 63: 2134-2138.
14. Work E, Nielsen OS, Bentzen SM, Fode K, Palshof T. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. J Clin Oncol 1997; 15: 3030-3037.
15. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: A randomized study. J Clin Oncol 1997; 15: 893-900.
16. Perry MC, Herndon JE, 3rd, Eaton WL, Green MR. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: An update of Cancer and Leukemia Group B Study 8083. J Clin Oncol 1998; 16: 2466-2467.
17. Skarlos DV, Samantas E, Briassoulis E et al. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol 2001; 12: 1231-1238.
18. James LE, Spiro S, O'Donnell KM et al. A randomised study of timing of thoracic irradiation in small cell lung cancer (SCLC) - Study 8. Lung Cancer 2003; 41 (S23).
19. Murray N, Coy P, Pater JL et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993; 11: 336-344.
20. Takada M, Fukuoka M, Kawahara M et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002; 20: 3054-3060.
21. Gregor A, Drings P, Burghouts J et al. Randomized trial of aternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: A European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. J Clin Oncol 1997; 15: 2840-2849.
22. Bonner JA, Sloan JA, Shanahan TG et al. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited-stage small-cell lung carcinoma. J Clin Oncol 1999; 17: 2681-2691.
23. Lebeau B, Urban T, Brechot JM et al. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. 'Petites Cellules' Group. Cancer 1999; 86: 1480-1487.
24. Turrisi AT, 3rd, Kim K, Blum R et al. Twice-dairy compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999; 340: 265-271.
25. Harari PM, Mehta MP, Ritter MA, Petereit DG. Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors. Semin Radiat Oncol 2003; 13: 3-12.
26. Sundstrom S, Bremnes RM, Kaasa S et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: Results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol 2002; 20: 4665-4672.
27. Mascaux C, Paesmans M, Berghmans T et al. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000; 30: 23-36.
28. Pujol JL, Carestia L, Daures JP. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer 2000; 83: 8-15.
29. Johnson DH, Bass D, Einhorn LH et al. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: A randomized trial of the Southeastern Cancer Study Group. J Clin Oncol 1993; 11: 1223-1229.
30. Masutani M, Ochi Y, Kadota A et al. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: Randomized trial, can it improve survival of patients with good prognostic factors? Oncol Rep 2000; 7: 305-310.
31. Thatcher N, Girling DJ, Hopwood P, Sambrook RJ, Qian W, Stephens RJ. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: Results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party. J Clin Oncol 2000; 18: 395-404.
32. Wolf M, Hans K, Drings P. Treatment intensification with GM-CSF in patients with non-metastatic small cell lung cancer (NSCLC). Results of a multicenter trial including 330 patients. Proc Am Soc Clin Oncol 1996; 15(270): (Abstr 716).
33. Steward WP, von Pawel J, Gatzemeier U et al. Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: A prospective randomized study of 300 patients. J Clin Oncol 1998; 16: 642-50.
34. Fried DB, Morris DE, Poole C et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 2004; 22: 4785-4793.